Taro Pharmaceutical Industries (NYSE:TARO) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a research report released on Sunday morning. The firm issued a strong-buy rating on the stock. Separately, HC Wainwright cut Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 target price on the stock. in […]

Related Keywords

Canada ,Switzerland ,Israel ,United States ,Swiss ,American , ,Mitsubishi Ufj ,Us Bancorp ,American Century Companies Inc ,Taro Pharmaceutical Industries ,News Ratings For Taro Pharmaceutical Industries Daily ,Dimensional Fund Advisors ,Banking Corp ,Taro Pharmaceutical Industries Stock Down ,Taro Pharmaceutical Industries Ltd ,Swiss National Bank ,Taro Pharmaceutical Industries Company Profile ,Free Report ,Pharmaceutical Industries Stock Down ,Pharmaceutical Industries ,Get Free Report ,National Bank ,Century Companies ,Fund Advisors ,Pharmaceutical Industries Ltd ,Taro Pharmaceutical Industries Daily ,Nyse Taro ,Taro ,Medical ,Initiated Coverage ,Stocknews Com ,